IDEXX LABORATORIES INC /DE — Director's Dealing 2019

Feb 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2019-02-14

Reporting Person: Turner Kathy V (Corporate Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-14	Common Stock	M	188	—	Acquired	3421	Direct
2019-02-14	Common Stock	M	221	—	Acquired	3642	Direct
2019-02-14	Common Stock	M	212	—	Acquired	3854	Direct
2019-02-14	Common Stock	M	211	—	Acquired	4065	Direct
2019-02-14	Common Stock	F	233	$206.94	Disposed	3832	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-14	Non-Qualified Stock Option (right-to-buy)	$206.94	M	8366	Acquired	2029-02-13	Common Stock (8366)	Direct
2019-02-14	Incentive Stock Option (right-to-buy)	$206.94	M	483	Acquired	2029-02-13	Common Stock (483)	Direct
2019-02-14	Restricted Stock Unit	$	M	906	Acquired		Common Stock (906)	Direct
2019-02-14	Restricted Stock Unit	$	M	188	Disposed		Common Stock (188)	Direct
2019-02-14	Restricted Stock Unit	$	M	221	Disposed		Common Stock (221)	Direct
2019-02-14	Restricted Stock Unit	$	M	212	Disposed		Common Stock (212)	Direct
2019-02-14	Restricted Stock Unit	$	M	211	Disposed		Common Stock (211)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	100	Indirect

Footnotes

F1: Includes a total of 74 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 28, 2018, September 30, 2018 and December 31, 2018.

F2: The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.

F3: Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2020.

F4: Grant of option to buy shares of Issuer common stock that becomes exercisable on the fifth anniversary of the date of grant.

F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F6: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2016. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split").

F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2017.

F8: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.

F9: 7. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.

F10: Not applicable.